RO96749A2 - Medicament vasoactif - Google Patents

Medicament vasoactif

Info

Publication number: RO96749A2
Authority: RO; Romania
Prior art keywords: rutacil; drug; caused; effect; vasoactive
Prior art date: 1987-02-11

Application number

RO87126978A

Other languages

English (en)

Romanian (ro)

Other versions

RO96749B1 (ro

Inventor

Nicolae Oita

Dumitru Dobrescu

Ion Neacsu

Vasile Cindea

Mihai Lazar

Original Assignee

Institutul De Medicina Si Farmacie,Ro

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-11

Filing date

1987-02-11

Publication date

1989-04-28

1987-02-11 Application filed by Institutul De Medicina Si Farmacie,Ro filed Critical Institutul De Medicina Si Farmacie,Ro

1987-02-11 Priority to RO126978A priority Critical patent/RO96749B1/ro

1989-04-28 Publication of RO96749A2 publication Critical patent/RO96749A2/fr

1989-04-29 Publication of RO96749B1 publication Critical patent/RO96749B1/ro

Links

230000002227 vasoactive effect Effects 0.000 title abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
UMNLDZWTFUCCBQ-NDPVGZFXSA-N [2-acetyloxy-4-[5,7-dihydroxy-4-oxo-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-yl]phenyl] acetate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(OC(C)=O)C(OC(C)=O)=CC=2)=O)O1 UMNLDZWTFUCCBQ-NDPVGZFXSA-N 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
230000017531 blood circulation Effects 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
229930003935 flavonoid Natural products 0.000 abstract 1
150000002215 flavonoids Chemical class 0.000 abstract 1
235000017173 flavonoids Nutrition 0.000 abstract 1
230000001976 improved effect Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
229910001425 magnesium ion Inorganic materials 0.000 abstract 1
239000011664 nicotinic acid Substances 0.000 abstract 1
231100000956 nontoxicity Toxicity 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
230000003019 stabilising effect Effects 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1
239000011708 vitamin B3 Substances 0.000 abstract 1
235000019160 vitamin B3 Nutrition 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

RO126978A 1987-02-11 1987-02-11 Medicament vasoactiv RO96749B1 (ro)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
RO126978A RO96749B1 (ro)	1987-02-11	1987-02-11	Medicament vasoactiv

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
RO126978A RO96749B1 (ro)	1987-02-11	1987-02-11	Medicament vasoactiv

Publications (2)

Publication Number	Publication Date
RO96749A2 true RO96749A2 (fr)	1989-04-28
RO96749B1 RO96749B1 (ro)	1989-04-29

Family

ID=20120412

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RO126978A RO96749B1 (ro)	1987-02-11	1987-02-11	Medicament vasoactiv

Country Status (1)

Country	Link
RO (1)	RO96749B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997014423A1 (fr) *	1995-10-17	1997-04-24	Leniger Follert Elfriede	Medicament pour traiter des maladies arterielles obliterantes, des micro-angiopathies et des troubles microcirculatoires

1987
- 1987-02-11 RO RO126978A patent/RO96749B1/ro unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997014423A1 (fr) *	1995-10-17	1997-04-24	Leniger Follert Elfriede	Medicament pour traiter des maladies arterielles obliterantes, des micro-angiopathies et des troubles microcirculatoires

Also Published As

Publication number	Publication date
RO96749B1 (ro)	1989-04-29

Similar Documents

Publication	Publication Date	Title
ES2340939T3 (es)	2010-06-11	Utilizacioin del treprostinil para tratar las ulceras de pie diabeticas neuropaticas.
AU762481C (en)	2004-08-19	Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
IT1261849B (it)	1996-06-03	Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
BR0109336A (pt)	2003-06-24	Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
ES2171469T3 (es)	2002-09-16	Composicion administrada por via nasal y preparacion que la contiene.
IT1270594B (it)	1997-05-07	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
NO920740D0 (no)	1992-02-25	Doseringsform for oral administrering av hypoglykemisk glipizid
Joy et al.	1960	Optic and peripheral neuritis: probable effect of prolonged chloramphenicol therapy
IT1256651B (it)	1995-12-12	Composizione farmaceutica a rilascio controllato in sospensione liquida
KR910005858A (ko)	1991-04-27	지방산 요법
DE69322251D1 (de)	1999-01-07	Medizinische zusammensetzung
KR970025615A (ko)	1997-06-24	암 전이 억제제
IT9048057A1 (it)	1991-12-13	Impiego di uridina nel trattamento farmacologico delle complicazioni periferiche del diabete
ES2139842T3 (es)	2000-02-16	Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
KR970032872A (ko)	1997-07-22	아세틸살리실산을 함유하는 피부 손상 처치용 약물
RO96749A2 (fr)	1989-04-28	Medicament vasoactif
EP0803256A4 (fr)	2000-07-05	Medicaments destines a soulager les effets secondaires provoques par des immunodepresseurs
McCarty	1984	High-chromium yeast for acne?
ES2043608T3 (es)	1994-01-01	Procedimiento para la preparacion de composiciones farmaceuticas con acetil-l-carnitina para el tratamiento terapeutico de condicones de shock.
ATE91890T1 (de)	1993-08-15	Herstellung eines arzneimittels gegen arthritis und rheumatismus.
US3442899A (en)	1969-05-06	Treatment of arteriosclerotic and arteriospastic diseases with 1-(beta-hydroxyethyl) 2-methyl - 5 - nitroimidazole
KR830008678A (ko)	1983-12-14	진통 조성물
HINE	1958	Severe angioneurotic edema during chlorpromazine therapy
RU2048809C1 (ru)	1995-11-27	Способ улучшения адаптации организма человека
Fujita et al.	1988	A clinical experience of fosfomycin tablet on cystitis